Stock Events

Oxford Nanopore Technologies 

€1.85
52
+€0.12+6.82% Wednesday 16:46

Statistics

Day High
1.85
Day Low
1.7
52W High
-
52W Low
-
Volume
15
Avg. Volume
-
Mkt Cap
336.88M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

3SepExpected
Q2 2021
Q4 2021
Q2 2022
Q4 2023
Q1 2024
Q2 2024
-9.99
-6.66
-3.33
0
Expected EPS
-7.71223
Actual EPS
-8.67625875

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4R0.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.93B
Illumina offers sequencing and array-based solutions for genetic and genomic analysis, competing directly in the DNA sequencing market.
Pacific Biosciences of California
PACB
Mkt Cap373.36M
Pacific Biosciences provides long-read sequencing technologies, directly competing with Oxford Nanopore's long-read sequencing capabilities.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific offers a range of sequencing solutions and genetic analysis tools, competing in the broader genomics and molecular diagnostics market.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products, including droplet digital PCR systems, which compete in the genomics space.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid technology market.
Roche
RHHBY
Mkt Cap272.83B
Roche Holding AG, through its acquisition of GenMark Diagnostics, competes in the next-generation sequencing and molecular diagnostics market.
Agilon Health
AGL
Mkt Cap1.68B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, competing in the life sciences and applied chemical markets for genomics and molecular diagnostics.
Bionano Genomics
BNGO
Mkt Cap42.14M
Bionano Genomics offers the Saphyr system for genome analysis, competing in the structural variation detection and genome mapping space.
Fulgent Genetics
FLGT
Mkt Cap683.49M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics markets with a focus on next-generation sequencing.

About

Oxford Nanopore Technologies Limited develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an alternative lab equipment. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data, as well as Q-Line systems to run nanopore-based sequencing in regulated environments. The company sells its products online. Oxford Nanopore Technologies Limited was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. The company was incorporated in 2005 and is based in Oxford, the United Kingdom.
Show more...
CEO
Ms. Lois K. Zabrocky
Employees
527
Country
GB
ISIN
GB00BP6S8Z30
WKN
000A3C307

Listings